Latest Biotech News

Researchers at the University of Illinois Urbana-Champaign engineered a novel solid-state nanopore platform using 2D materials, advancing label-free single-biomolecule detection technology....

A study led by Professor Philip Moons demonstrated the capability of AI, using Google NotebookLM, to produce podcasts summarizing scientific research effectively. The AI-generated content received...

The MOVEO project officially launched in Málaga, Spain, brings together 16 partners from nine countries to develop sustainable, integrated transport solutions across Europe. Funded by Horizon...

The extensive US budget bill under Senate consideration includes significant changes impacting pharma, including reform proposals for the Inflation Reduction Act’s Medicare drug price negotiation...

Genetic testing firm 23andMe agreed to be acquired by a nonprofit led by co-founder Anne Wojcicki for $305 million, prevailing in a final bidding round over Regeneron. This transaction concludes a...

Innovent Biologics advances their PD-1 × IL-2 antibody fusion IBI363 into registrational studies after demonstrating Phase I/II efficacy across three cold tumor types. This bispecific approach...

Sarepta Therapeutics has suspended shipments of its Duchenne muscular dystrophy gene therapy, Elevidys, for non-ambulatory patients following a second fatality caused by acute liver failure. Both...

Anne Wojcicki, co-founder and ex-CEO of 23andMe, has prevailed in a bankruptcy auction for the company's assets by bidding $305 million through her nonprofit TTAM Research Institute. This offer...

The FDA has approved pembrolizumab, an immune checkpoint inhibitor, for patients with resectable locally advanced head and neck squamous cell carcinoma expressing PD-L1 (CPS≥1). Approval was based...

Recent studies have uncovered novel insights into Parkinson’s disease pathology and progression. Researchers identified changes in cutaneous nerve fibers linked to Parkinson’s and atypical...

Engineering innovations include a novel solid-state nanopore sensing platform developed by University of Illinois researchers enabling label-free single-biomolecule detection, enhancing prospects...

The 25-year milestone of the Human Genome Project's first draft is marked by reflections from key figures, including Francis Collins and J. Craig Venter. Their insights highlight the...

The proteomics field is witnessing strategic partnerships aligning gene sequencing with advanced protein analysis technologies. Ultima Genomics collaborates with Olink Proteomics, leveraging...

Bristol Myers Squibb appoints Chris Shibutani, M.D., a former Goldman Sachs biotech analyst and practicing anesthesiologist, as EVP and Chief Strategy Officer to guide long-term strategy and...

Promising research spans biomaterial development to reverse heart aging by modulating extracellular matrix properties, and drone technology equipped with AI gas sensors to enable rapid detection...

Year-to-date biopharma financing continues robustly with significant funds raised in both public and private rounds, reflecting sustained investor interest despite industry layoffs. Market...

Sarepta Therapeutics has suspended Elevidys shipments for non-ambulatory Duchenne muscular dystrophy patients following a second acute liver failure death. Both fatalities involved boys reliant on...

Anne Wojcicki, co-founder and former CEO of 23andMe, through her nonprofit TTAM Research Institute, has won a bidding war to purchase most of 23andMe’s assets for $305 million. This new agreement...

Recent studies illuminate Parkinson’s disease pathology through peripheral nervous system insights and brain fluid dynamics. One cohort study detailed structural and functional alterations in...

The FDA has approved pembrolizumab as a perioperative treatment for patients with resectable locally advanced head and neck squamous cell carcinoma expressing PD-L1. The decision follows the phase...